Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7773]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Advanced prostate cancer overview: Expert discussion
Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders
Advanced prostate cancer overview: Expert discussion ( Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders )
27 Jan 2016
Utilising disease heterogeneity and emerging biomarkers to individualise...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
22 Jan 2016
Avelumab for metastatic urothelial carcinoma: JAVELIN trial
Dr Andrea Apolo - National Cancer Institute, Maryland, USA
Avelumab for metastatic urothelial carcinoma: JAVELIN trial ( Dr Andrea Apolo - National Cancer Institute, Maryland, USA )
8 Jan 2016
New treatment options in metastatic prostate cancer
Dr Neal Shore and Dr Axel Merseburger
New treatment options in metastatic prostate cancer ( Dr Neal Shore and Dr Axel Merseburger )
8 Jan 2016
Atezolizumab for platinum-treated locally advanced or metastatic urothelial...
Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )
8 Jan 2016
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer
Prof Eleni Efstathiou and Prof Nick James
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )
7 Jan 2016
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours
Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )
7 Jan 2016
Functional characterisation of therapeutic targets through comparative...
Dr Igor Vivanco - Institute Of Cancer Research, London, UK
Functional characterisation of therapeutic targets through comparative pharmacology ( Dr Igor Vivanco - Institute Of Cancer Research, London, UK )
22 Dec 2015
Mouse models for complex aspects in human cancer
Dr Peter Bouwman - Netherlands Cancer Institute (NKI), Amsterdam, Netherlands
Mouse models for complex aspects in human cancer ( Dr Peter Bouwman - Netherlands Cancer Institute (NKI), Amsterdam, Netherlands )
22 Dec 2015
The DNA damage response
Dr Helge Gad - Karolinska Institutet, Stockholm, Sweden
The DNA damage response ( Dr Helge Gad - Karolinska Institutet, Stockholm, Sweden )
22 Dec 2015
Drug resistance mechanisms
Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands
Drug resistance mechanisms ( Dr Floris Groenendijk - Erasmus Medical Center, Rotterdam, Netherlands )
22 Dec 2015
Improving cancer control in low-middle income countries and creating a global...
Mrs Ann McMikel - American Cancer Society, Atlanta, USA
Improving cancer control in low-middle income countries and creating a global network of expertise ( Mrs Ann McMikel - American Cancer Society, Atlanta, USA )
17 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation